Literature DB >> 7575117

Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial.

J T Mäkelä1, S O Laitinen, M I Kairaluoma.   

Abstract

OBJECTIVE: To determine whether an intensified follow-up of patients with colorectal cancer can lead to improved reresectability and a better long-term survival.
DESIGN: A prospective randomized trial of 106 patients.
SETTING: Oulu University Hospital, a referral center in northern Finland. PATIENTS: A total of 106 consecutive patients who underwent radical resection for colorectal cancer, 54 of whom were randomized into a conventional follow-up group and 52 into an intensified follow-up group. MAIN OUTCOME MEASURES: After a 5-year follow-up, the time of detection of recurrence, the recurrence rates, the first method showing recurrence, the mode of recurrence, reresectability, and survival were compared between the groups.
RESULTS: The recurrences were identified earlier in the intensified follow-up group than in the conventional follow-up group (mean +/- SD, 10 +/- 5 months vs 15 +/- 10 months). The overall recurrence rate was 41%, with 39% in the conventional group and 42% in the intensified group. Carcinoembryonic antigen determination was the most common method showing recurrence in both groups. Endoscopy and ultrasound were beneficial in the intensified follow-up group, but computed tomography failed to improve the diagnostics. The mode of recurrence did not differ between the groups. Radical resections were performed on 19% (8/43) of the patients, 14% (3/21) in the conventional group and 22% (5/22) in the intensified group. The cumulative 5-year survival was 54% in the conventional group and 59% in the intensified group.
CONCLUSION: Earlier detection of recurrent colorectal cancer by intensified follow-up does not lead to either significantly increased reresectability or improved 5-year survival.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575117     DOI: 10.1001/archsurg.1995.01430100040009

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  72 in total

1.  Management of colorectal cancer.

Authors:  A Melville; T A Sheldon; R Gray; A Sowden
Journal:  Qual Health Care       Date:  1998-06

2.  Surveillance after curative resection of colorectal cancer.

Authors:  Adena Scheer; Rebecca Ann C Auer
Journal:  Clin Colon Rectal Surg       Date:  2009-11

3.  Intensive or not surveillance of patients with colorectal cancer after curative resection.

Authors:  Gerardo Rosati
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

4.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 5.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

Review 6.  Colorectal cancer surveillance: what's new and what's next.

Authors:  Johnie Rose; Knut Magne Augestad; Gregory S Cooper
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 7.  Long-term follow-up for melanoma patients: is there any evidence of a benefit?

Authors:  Natasha M Rueth; Kate D Cromwell; Janice N Cormier
Journal:  Surg Oncol Clin N Am       Date:  2015-01-24       Impact factor: 3.495

8.  Follow-up recommendations for colon cancer.

Authors:  W Donald Buie; Jo-Anne P Attard
Journal:  Clin Colon Rectal Surg       Date:  2005-08

9.  The role of postoperative surveillance in colorectal cancer.

Authors:  Kerry Hammond; David A Margolin
Journal:  Clin Colon Rectal Surg       Date:  2007-08

10.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.